Attached files
file | filename |
---|---|
EX-32.2 - CERTIFICATION - PharmaCyte Biotech, Inc. | pharmacyte_10k-ex3202.htm |
EX-32.1 - CERTIFICATION - PharmaCyte Biotech, Inc. | pharmacyte_10k-ex3201.htm |
EX-31.2 - CERTIFICATION - PharmaCyte Biotech, Inc. | pharmacyte_10k-ex3102.htm |
EX-31.1 - CERTIFICATION - PharmaCyte Biotech, Inc. | pharmacyte_10k-ex3101.htm |
EX-21.1 - LIST OF SUBSIDIARIES - PharmaCyte Biotech, Inc. | pharmacyte_10k-ex2101.htm |
10-K - FORM 10-K - PharmaCyte Biotech, Inc. | pharmacyte_10k-043017.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
PharmaCyte Biotech, Inc.
23046 Avenida de la Carlota, Suite 600
Laguna Hills, CA 92653
We hereby consent to the incorporation by reference in the Registration Statement on Amendment No. 1 to Form S-3 (No. 333-199440) of PharmaCyte Biotech, Inc., of our report dated July 27, 2017, with respect to the consolidated financial statements and schedule of PharmaCyte Biotech, Inc. as of April 30, 2017 and April 30, 2016, and the related consolidated statements of operations, stockholders' equity, and cash flows for the years then ended, included in the April 30, 2017 annual report on Form 10-K of PharmaCyte Biotech, Inc.
/s/ Armanino LLP
San Jose, California
July 27, 2017